Clinical impact and drivers of non-adherence to maintenance medication for inflammatory bowel disease

Bibliography

• Carter MJ, Lobo AJ, Travis SPL, Guidelines for the management of inflammatory bowel disease in adults. Gut 2004;10(Suppl V):v1-16
   Google Scholar
• Bernal I, Domenech E, Garcia-Planella E, Medication-taking behavior in a cohort of patients with inflammatory bowel disease. Dig Dis Sci 2006;51:2165-9
   PubMed Web of Science ®Google Scholar
• Feagan BG. Maintenance therapy for inflammatory bowel disease. Am J Gastroenterol 2003;98:S6-17
   PubMed Web of Science ®Google Scholar
• Hanauer S, Present DH, Jones WK, The state of the art in the management of inflammatory bowel disease: update and recent advances in colorectal cancer prevention. Clin Courier 2004;22:1-8
   Google Scholar
• Dignass A, Van Asche G, Lindasy JO, The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management. J Crohn's Colitis 2010;4:28-62
   Google Scholar
• Travis SPL, Stange EF, Lemann M, European evidence-based Consensus on the management of ulcerative colitis: current management. J Crohn's Colitis 2008;2:24-62
   Google Scholar
• D'Haens G, Baert F, van Assche G, Belgian inflammatory bowel disease research group; north-holland gut club. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Lancet 2008;371:660-7
   PubMed Web of Science ®Google Scholar
• Colombel JF, Sandborn WJ, Reinisch W, Infliximab, Azathioprine or combination therapy for Crohn's disease. N Engl J Med 2010;362:1383-95
   PubMed Web of Science ®Google Scholar
• Biancone L, Michetti P, Travis S, European evidence-based Consensus on the management of ulcerative colitis: special situations. J Crohn's Colitis 2008;2:63-92
   Google Scholar
• Horne R, Weinman J, Barber N, Concordance, adherence and complicance in medicine taking: a conceptual map and research priorities. National Institute for Health Research Service Delivery and Organisation R&D, London; 2006
   Google Scholar
• Shale MJ, Riley SA. Studies of compliance with delayed-release mesalazine therapy in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2003;18:191-8
   PubMed Web of Science ®Google Scholar
• Kane SV, Cohen RD, Aikens JE, Hanauer SB. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol 2001;96:2929-33
   PubMed Web of Science ®Google Scholar
• Bokemeyer B, Teml A, Roggel C, Adherence to thiopurine treatment in out-patients with Crohn's disease. Aliment Pharmacol Ther 2007;26:217-25
   PubMed Web of Science ®Google Scholar
• Cerveny P, Bortlik M, Kubena A, Nonadherence in inflammatory bowel disease: results of factor analysis. Inflamm Bowel Dis 2007;13:1244-9
   PubMed Web of Science ®Google Scholar
• Cerveny P, Bortlik M, Vlcek J, Non-adherence to treatment in inflamatory bowel disease in Czech Republic. J Crohn's Colitis 2007;1:77-81
   Google Scholar
• Dewulf NDLS, Monteiro RA, Passos ADC, Compliance to drug therapy in inflammatory bowel diseases outpatients from an university hospital [Portuguese]. Arq Gastroenterol 2007;44:289-96
   PubMedGoogle Scholar
• D'Inca R, Bertomoro P, Mazzocco K, Risk factors for non-adherence to medication in inflammatory bowel disease patients. Aliment Pharmacol Ther 2008;27:166-72
   PubMed Web of Science ®Google Scholar
• Ediger JP, Walker JR, Graff L, Predictors of medication adherence in inflammatory bowel disease. Am J Gastroenterol 2007;102:1417-26
   PubMed Web of Science ®Google Scholar
• Horne R, Parham R, Driscoll R, Patients' attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease. Inflamm Bowel Dis 2009;15:837-44
   PubMed Web of Science ®Google Scholar
• Kane S, Huo D, Magnanti K. A pilot feasibility study of once daily versus conventional dosing mesalamine for maintenance of ulcerative colitis. Clin Gastroenterol Hepatol 2003;1:170-3
   PubMed Web of Science ®Google Scholar
• Karbach U, Degen I, Ewe K. Extent of drug compliance in Crohn disease patients – study of a special ambulatory care unit of a university clinic. Z Gastroenterol 1984;22:573-9
   PubMed Web of Science ®Google Scholar
• Lopez San Roman A, Bermejo F, Carrera E, Adherence to treatment in inflammatory bowel disease. Rev Esp Enferm Dig 2005;97:249-57
   PubMed Web of Science ®Google Scholar
• Mantzaris GJ, Roussos A, Kalantzis C, How adherent to treatment with azathioprine are patients with Crohn's disease in long-term remission? Inflamm Bowel Dis 2007;13:446-50
   PubMed Web of Science ®Google Scholar
• Nigro G, Angelini G, Grosso SB, Psychiatric predictors of noncompliance in infl ammatory bowel disease: psychiatry and compliance. J Clin Gastroenterol 2001;32:66-8
   PubMed Web of Science ®Google Scholar
• Sewitch MJ, Abrahamowicz M, Barkun A, Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol 2003;98:1535-44
   PubMed Web of Science ®Google Scholar
• Waters BM, Jensen L, Fedorak RN. Effects of formal education for patientswith infl ammatory bowel disease: a randomized controlled trial. Can J Gastroenterol 2005;19:235-44
   PubMed Web of Science ®Google Scholar
• Bhatt J, Patil S, Joshi A, Self-reported treatment adherence in inflammatory bowel disease in Indian patients. Indian J Gastroenterol 2009;28:143-6
   PubMedGoogle Scholar
• Kane S, Huo D, Aikens J, Hanauer S. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am J Med 2003;114:39-43
   PubMed Web of Science ®Google Scholar
• Higgins PD, Rubin DT, Kaulback K, Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flares. Aliment Pharmacol Ther 2009;29(3):247-57
   PubMed Web of Science ®Google Scholar
• Kane S, Shaya F. Medication non-adherence is associated with increased medical health care costs. Dig Dis Sci 2008;53(4):1020-4
   PubMed Web of Science ®Google Scholar
• Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment. JAMA 2002;288:2880-3
   PubMed Web of Science ®Google Scholar
• Haynes RB, Ackloo E, Sahota N, Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008:CD000011
   PubMed Web of Science ®Google Scholar
• Wroe LE. Intentional and unintentional nonadherence: a study of decision making. J Behav Med 2002;25:355-72
   PubMed Web of Science ®Google Scholar
• Bermejo F, Lopez-San Roman A, Algaba A, Factors that modify therapy adherence in patients with inflammatory bowel disease. J Crohn's Colitis 2010;4:422-6
   Google Scholar
• Nahon S, Lahmek P, Saas C, Socioeconomic and Psychological factors associated with nonadherence to treatment in inflammatory bowel disease patients: results of the ISSEO study. Inflamm Bowel Dis 2010. [Epub ahead of print]
   Google Scholar
• Moshkovska T, Stone MA, Clatworthy J, An investigation of medication adherence to 5-aminosalicylic acid therapy in patients with ulcerative colitis, using self-report and urinary drug excretion measurements. Aliment Pharmacol Ther 2009;30:1118-27
   PubMed Web of Science ®Google Scholar
• Trindade A, Ehrlich A, Kornbluth A, Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence. Inflamm Bowel Dis 2010. [Epub ahead of print]
   Google Scholar
• Lakatos PL, Czegledi Z, David G, Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease. J Crohns Colitis 2010;4(3):283-90
   PubMed Web of Science ®Google Scholar
• Hawthorne AB, Rubin G, Ghosh S. Review article: medication non-adherence in ulcerative colitis – strategies to improve adherence with mesalazine and other maintenance therapies. Aliment Pharmacol Ther 2008;27:1157-66
   PubMed Web of Science ®Google Scholar
• Krueger KP, Felkey BG, Berger BA. Improving adherence and persistence: a review and assessment of interventions and description of steps toward a national adherence initiative. Am J Pharm Assoc (Wash) 2003;43:668-78
   PubMedGoogle Scholar
• Robinson GL, Gilbertson AD, Litwack L. The effects of a psychiatric patient education to medication program on post discharge compliance. Psychiatric Q 1987;58:113-18
   Google Scholar
• Bregenzer A, Lange A, Fuerst A. Patient education in inflammatory bowel disease does not influence patients knowledge and long-term psychosocial well-being. Z Gastroenterol 2005;43:367-71
   PubMed Web of Science ®Google Scholar
• Moss AC, Chaudhary N, Tukey M, Impact of a patient-support program on mesalamine adherence in patients with ulcerative colitis – a prospective study. J Crohn's Colitis 2010;4:171-5
   Google Scholar
• Moshkovska T, Stone MA, Smith RM, Impact of a tailored patient preference intervention in adherence to 5-aminosalicylic acid medication in ulcerative colitis: results from an exploratory randomized controlled trial. Inflamm Bowel Dis 2011. [Epub ahead of print]
   Google Scholar